Frontiers in Immunology (Mar 2018)

Macrophage Transactivation for Chemokine Production Identified as a Negative Regulator of Granulomatous Inflammation Using Agent-Based Modeling

  • Daniel Moyo,
  • Daniel Moyo,
  • Lynette Beattie,
  • Paul S. Andrews,
  • Paul S. Andrews,
  • John W. J. Moore,
  • Jon Timmis,
  • Jon Timmis,
  • Amy Sawtell,
  • Stefan Hoehme,
  • Adam T. Sampson,
  • Paul M. Kaye

DOI
https://doi.org/10.3389/fimmu.2018.00637
Journal volume & issue
Vol. 9

Abstract

Read online

Cellular activation in trans by interferons, cytokines, and chemokines is a commonly recognized mechanism to amplify immune effector function and limit pathogen spread. However, an optimal host response also requires that collateral damage associated with inflammation is limited. This may be particularly so in the case of granulomatous inflammation, where an excessive number and/or excessively florid granulomas can have significant pathological consequences. Here, we have combined transcriptomics, agent-based modeling, and in vivo experimental approaches to study constraints on hepatic granuloma formation in a murine model of experimental leishmaniasis. We demonstrate that chemokine production by non-infected Kupffer cells in the Leishmania donovani-infected liver promotes competition with infected KCs for available iNKT cells, ultimately inhibiting the extent of granulomatous inflammation. We propose trans-activation for chemokine production as a novel broadly applicable mechanism that may operate early in infection to limit excessive focal inflammation.

Keywords